Stockscreener 앱 받기
1.81
0.61%
0.00
전일 마감가:
$1.81
열려 있는:
$1.9
하루 거래량:
24,902
Relative Volume:
0.32
시가총액:
$65.76M
수익:
-
순이익/손실:
$-14.47M
주가수익비율:
-1.4597
EPS:
-1.24
순현금흐름:
$-12.19M
1주 성능:
-6.61%
1개월 성능:
+7.76%
6개월 성능:
-25.36%
1년 성능:
-17.60%
1일 변동 폭
$1.80
$1.90
1주일 범위
$1.72
$1.9186
52주 변동 폭
$1.45
$3.48
Heartbeam Inc Stock (BEAT) Company Profile
명칭
Heartbeam Inc
전화
408-899-4443
주소
2118 WALSH AVE., SUITE 210, SANTA CLARA
BEAT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BEAT
Heartbeam Inc
|
1.80 | 65.76M | 0 | -14.47M | -12.19M | -1.24 |
|
VEEV
Veeva Systems Inc
|
238.70 | 36.73B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
59.62 | 10.64B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
54.84 | 9.30B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
92.04 | 7.43B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
41.35 | 6.34B | 906.14M | -52.62M | 89.62M | -0.3621 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-09-11 | 개시 | Needham | Buy |
| 2020-09-02 | 개시 | Robert W. Baird | Neutral |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2019-08-02 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-04-26 | 재확인 | Dougherty & Company | Buy |
| 2018-07-26 | 재확인 | Lake Street | Buy |
| 2018-04-26 | 재확인 | The Benchmark Company | Buy |
| 2018-02-23 | 재확인 | Dougherty & Company | Buy |
| 2017-11-08 | 재확인 | Dougherty & Company | Buy |
| 2017-10-26 | 개시 | Raymond James | Outperform |
| 2017-10-24 | 개시 | SunTrust | Buy |
| 2017-08-09 | 재확인 | Dougherty & Company | Buy |
| 2017-07-19 | 재확인 | The Benchmark Company | Buy |
| 2017-04-11 | 재확인 | Dougherty & Company | Buy |
| 2016-12-02 | 개시 | Dougherty & Company | Buy |
| 2016-09-13 | 개시 | Sidoti | Buy |
| 2016-08-03 | 재확인 | The Benchmark Company | Buy |
| 2015-07-28 | 재확인 | Dougherty & Company | Buy |
| 2013-10-24 | 개시 | The Benchmark Company | Buy |
| 2013-08-21 | 개시 | Dougherty & Company | Buy |
모두보기
Heartbeam Inc 주식(BEAT)의 최신 뉴스
HeartBeam Appoints CEO Robert Eno to Board - TipRanks
HeartBeam expands board, appoints CEO to director role By Investing.com - Investing.com India
HeartBeam expands board, appoints CEO to director role - Investing.com Australia
HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth - Bluefield Daily Telegraph
HeartBeam (NASDAQ: BEAT) Prices $10 Million Public Offering At $1.70 Per Share - Barchart.com
HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time - Bluefield Daily Telegraph
HeartBeam’s ECG technology shows promise in study for arrhythmia diagnosis - Yahoo Finance
HeartBeam Prepares to Unveil Q1 2025 Financial Results and Strategic Progress - citybuzz -
HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology - BioSpace
Strategic Collaboration with AccurKardia for Ambulatory ECG - openPR.com
Strategic Collaboration with AccurKardia for Ambulatory ECG Recording and Analysis to Advance Cardiac Monitoring Care: HeartBeam, Inc. (Nasdaq: BEAT) - The Globe and Mail
Strategic Collaboration with AccurKardia for Ambulatory ECG Recording and Analysis to Advance Cardiac Monitoring Care: HeartBeam, Inc. (Nasdaq: BEAT) | FinancialContent - FinancialContent
HeartBeam’s VALID-ECG Study of 12-Lead ECG Synthesis Tech Meets Endpoints - Medical Product Outsourcing
HeartBeam (BEAT) Achieves Key Milestones with Synthesized 12-Lea - GuruFocus
HeartBeam’s ECG software shows promise in clinical study - Investing.com
HeartBeam announces VALID-ECG pivotal study met primary endpoint - TipRanks
HeartBeam, AccurKardia Announce Strategic Collaboration - Diagnostic and Interventional Cardiology
HeartBeam names new auditor after Marcum resignation By Investing.com - Investing.com Nigeria
HeartBeam names new auditor after Marcum resignation - Investing.com
HeartBeam partners with AccurKardia to enhance cardiac care - Yahoo Finance
HeartBeam and AccurKardia partner on ECG tech By Investing.com - Investing.com South Africa
HeartBeam (NASDAQ: BEAT) And AccurKardia Partner To Advance Remote ECG Monitoring - Barchart.com
HeartBeam, AccurKardia Begin Cardiac Monitoring Partnership - Medical Product Outsourcing
HeartBeam and AccurKardia partner on ECG tech - Investing.com
HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation - The Joplin Globe
Heartbeam stock touches 52-week low at $1.7 amid market challenges - Investing.com Canada
Heartbeam stock touches 52-week low at $1.7 amid market challenges By Investing.com - Investing.com South Africa
Benchmark maintains $8 target on Heartbeam stock post-Q4 report By Investing.com - Investing.com Australia
Benchmark maintains $8 target on Heartbeam stock post-Q4 report - Investing.com
HeartBeam Announces Automated Cardiac Detection Patent Granted for HeartBeam AIMIGo™ System - Business Wire
HeartBeam reports net loss of USD 4.9M in Q4 2024 - Medical Buyer
HeartBeam, Inc. (NASDAQ:BEAT) Q4 2024 Earnings Call Transcript - Insider Monkey
HeartBeam’s Earnings Call Highlights Strategic Progress - TipRanks
HeartBeam (NASDAQ: BEAT) Reports Q4 and Full-Year 2024 Financial Results, Highlights FDA Clearance and Commercial Progress - The Globe and Mail
HeartBeam Inc (BEAT) Q4 2024 Earnings Call Highlights: FDA Clearance and Strategic Moves By GuruFocus - Investing.com Canada
HeartBeam Advances Cardiac Care with FDA Clearance and New Innovations - TipRanks
Earnings call transcript: HeartBEAM Q4 2024 misses EPS forecasts - Investing.com
HeartBeam Reports Fourth Quarter and Full Year 2024 Results -March 13, 2025 at 05:31 pm EDT - Marketscreener.com
Heartbeam Inc reports results for the quarter ended December 31Earnings Summary - TradingView
HeartBeam Reports Fourth Quarter and Full Year 2024 Results - Business Wire
HeartBeam (NASDAQ: BEAT) To Present At Upcoming Investor And Industry Conferences - Barchart
HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025 - The Bakersfield Californian
Meet HeartBeam Executives: Key Investment Conferences Set for California Next Month - StockTitan
HeartBeam (NASDAQ: BEAT) to Present at Upcoming Investor and Industry Conferences - The Globe and Mail
HeartBeam to Host Fourth Quarter Full Year 2024 Results Conference Call on Thursday, March 13, 2025 at 4:30 p.m. Eastern Time - The Bakersfield Californian
HeartBeam's 2024 Earnings Call: Key Updates on Cardiac Tech Commercialization Coming March 13 - Stock Titan
HeartBeam (NASDAQ: BEAT) Underwriter Exercises Option, Increasing Gross Proceeds to $11.5M - The Globe and Mail
HeartBeam closes underwriter’s over-allotment option for PO - Medical Buyer
HeartBeam Raises $11.5M: What This Capital Injection Means for Its Commercial Launch Timeline - StockTitan
HeartBeam Announces Exercise and Closing of Underwriter’s Over-Allotment Option for Public Offering of Common Stock - Business Wire
Heartbeam CFO Tim Cruickshank buys $29,999 in company stock - Investing.com India
Heartbeam Inc (BEAT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.12%
2.25%
자본화:
|
볼륨(24시간):